Literature DB >> 31508226

Hepatology Clearance for Immunomodulation in Patients With Hepatitis B.

Tae Hoon Lee1,2, Thomas D Schiano1,3.   

Abstract

Entities:  

Year:  2019        PMID： 31508226      PMCID： PMC6726382          DOI： 10.1002/cld.757

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  16 in total

Review 1.  American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Authors:  K Rajender Reddy; Kimberly L Beavers; Sarah P Hammond; Joseph K Lim; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2014-10-31       Impact factor: 22.682

2.  Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.

Authors:  W Yeo; P K Chan; S Zhong; W M Ho; J L Steinberg; J S Tam; P Hui; N W Leung; B Zee; P J Johnson
Journal:  J Med Virol       Date:  2000-11       Impact factor: 2.327

Review 3.  Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.

Authors:  Guangqin Xiao; Jiayin Yang; Lunan Yan
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

4.  Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.

Authors:  S Huprikar; L Danziger-Isakov; J Ahn; S Naugler; E Blumberg; R K Avery; C Koval; E D Lease; A Pillai; K E Doucette; J Levitsky; M I Morris; K Lu; J K McDermott; T Mone; J P Orlowski; D M Dadhania; K Abbott; S Horslen; B L Laskin; A Mougdil; V L Venkat; K Korenblat; V Kumar; P Grossi; R D Bloom; K Brown; C N Kotton; D Kumar
Journal:  Am J Transplant       Date:  2015-02-23       Impact factor: 8.086

5.  Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.

Authors:  Wai-Kay Seto; Thomas Sau-Yan Chan; Yu-Yan Hwang; Danny Ka-Ho Wong; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Eric H Y Lau; Ka-Shing Cheung; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

6.  Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Authors:  Cindy M Weinbaum; Eric E Mast; John W Ward
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

8.  From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis.

Authors:  Kiran Motaparthi; Vladimir Stanisic; Abby S Van Voorhees; Mark G Lebwohl; Sylvia Hsu
Journal:  J Am Acad Dermatol       Date:  2013-11-09       Impact factor: 11.527

9.  Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.

Authors:  Jessica P Hwang; Mark R Somerfield; Devena E Alston-Johnson; Donna R Cryer; Jordan J Feld; Barnett S Kramer; Anita L Sabichi; Sandra L Wong; Andrew S Artz
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

10.  Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.

Authors:  Chih-An Shih; Wen-Chi Chen; Hsien-Chung Yu; Jin-Shiung Cheng; Kwok-Hung Lai; Jui-Ting Hsu; Hui-Chun Chen; Ping-I Hsu
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.